EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay

Thoa Ha, Angela Morgan, Meghan N Bartos, Katelyn Beatty, Benjamin Cogné, Dominique Braun, Céline B Gerber, Harald Gaspar, Anna M Kopps, Claudine Rieubland, Anna C E Hurst, David J Amor und 20 weitere

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Thoa Ha und 31 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, USA. Hauptthemen laut MEDLINE: Haploinsufficiency, Language Development Disorders. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, Alabama Genomic Health Initiative, Dutch Organization for Health Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The disconnected (disco)‐interacting protein 2 (DIP2) gene was first identified in D. melanogaster and contains a DNA methyltransferase‐associated protein 1 (DMAP1) binding domain, Acyl‐CoA synthetase domain and AMP‐binding sites. DIP2 regulates axonal bifurcation of the mushroom body neurons in D. melanogaster and is required for axonal regeneration in the neurons of C. elegans . The DIP2 homologues in vertebrates, Disco‐interacting protein 2 homolog A ( DIP2A ), Disco‐interacting protein 2 homolog B ( DIP2B ), and Disco‐interacting protein 2 homolog C ( DIP2C ), are highly conserved and expressed widely in the central nervous system. Although there is evidence that DIP2C plays a role in cognition, reports of pathogenic variants in these genes are rare and their significance is uncertain. We present 23 individuals with heterozygous DIP2C variants, all manifesting developmental delays that primarily affect expressive language and speech articulation. Eight patients had de novo variants predicting loss‐of‐function in the DIP2C gene, two patients had de novo missense variants, three had paternally inherited loss of function variants and six had maternally inherited loss‐of‐function variants, while inheritance was unknown for four variants. Four patients had cardiac defects (hypertrophic cardiomyopathy, atrial septal defects, and bicuspid aortic valve). Minor facial anomalies were inconsistent but included a high anterior hairline with a long forehead, broad nasal tip, and ear anomalies. Brainspan analysis showed elevated DIP2C expression in the human neocortex at 10–24 weeks after conception. With the cases presented herein, we provide phenotypic and genotypic data supporting the association between loss‐of‐function variants in DIP2C with a neurocognitive phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaploinsufficiencyLanguage Development DisordersChildChild, PreschoolFemaleHumansInfantMaleGenetic Predisposition to DiseasePhenotypeNeoplasm Proteins

Stichwörter der Autor:innen

DIP2DIP2Cdevelopmental delayintellectual disabilityspeech articulationspeech delay

Substanzen

DIP2C protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, San Francisco, USA.
  • Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • University of Melbourne, Parkville, Victoria, Australia.
  • Royal Children's Hospital, Parkville, Victoria, Australia.
  • Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

ORCID-Profile: Bert B A de Vries, Christiane Zweier, Anne Slavotinek

Förderung

  • NHGRI NIH HHS
  • Alabama Genomic Health Initiative
  • Dutch Organization for Health Research and Development
  • National Human Genome Research Institute

Zitieren

APA

Ha, T., Morgan, A., Bartos, M. N., Beatty, K., Cogné, B., Braun, D., Gerber, C. B., Gaspar, H., Kopps, A. M., Rieubland, C., Hurst, A. C. E., Amor, D. J., Nizon, M., Pasquier, L., Pfundt, R., Reis, A., Siu, V. M., Tessarech, M., Thompson, M. L., …, & Slavotinek, A. (2024). De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63559

Vancouver

Ha T, Morgan A, Bartos MN, Beatty K, Cogné B, Braun D, et al. De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63559

BibTeX
@article{Ha2024,
  author = {Ha, Thoa and Morgan, Angela and Bartos, Meghan N and Beatty, Katelyn and Cogné, Benjamin and Braun, Dominique and Gerber, Céline B and Gaspar, Harald and Kopps, Anna M and Rieubland, Claudine and Hurst, Anna C E and Amor, David J and Nizon, Mathilde and Pasquier, Laurent and Pfundt, Rolph and Reis, André and Siu, Victoria Mok and Tessarech, Marine and Thompson, Michelle L and Vincent, Marie and de Vries, Bert B A and Walsh, Matthew B and Wechsler, Stephanie Burns and Zweier, Christiane and Schnur, Rhonda E and Guillen Sacoto, Maria J and Margot, Henri and Masotto, Barbara and Palafoll, Maria Irene Valenzuela and Nawaz, Urwah and Voineagu, Irina and Slavotinek, Anne},
  title = {De novo variants predicting haploinsufficiency for DIP2C are associated with expressive speech delay},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63559}
}
Kostenlos starten →